DecisionQ, Roche, and Sharp Memorial Hospital to Unveil New Research Assay and Bayesian Models That Might Predict Breast Cancer Recurrence
9th Dec 2005, 14:42 GMT
Poster to Be Presented at the 2005 San Antonio Breast Cancer Symposium
DecisionQ, Roche, and Sharp Memorial Hospital to Unveil New Research Assay and Bayesian Models That Might Predict Breast Cancer Recurrence related news:
- DecisionQ, Roche, and Sharp Memorial Hospital to Unveil New Research Assay and Bayesian Models That Might Predict Breast Cancer Recurrence — PR Newswire: All Releases
- Genetic Test Helps Predict Breast Cancer Recurrence — MedicineNet Weekly News Digest
- Low-Fat Diet May Prevent Breast Cancer Recurrence — Breast Cancer Chronicles
- New External Study Demonstrates Strong Correlation of TriPath Imaging's ProEx Br Biomarkers with Risk of Breast Cancer Recurrence — FDA News News from StratCenter.com
- SABCS: Shorter Chemotherapy Regimen Plus Taxol Reduces Breast Cancer Recurrence — MedPage Today Hematology/Oncology
- Drug for cancer is successful — Scotsman.com News - Breast cancer
- Breast cancer survivors face more risks — HEALTH
- Genomic Health Announces Study Results Demonstrating Oncotype DX 's Ability to Quantify Risk for Local and Regional Breast Cancer Recurrence — Surgery News from StratCenter.com
- Breast Cancer Significantly Increases Risk of Other Cancers — MedPage Today Hematology/Oncology
- Second malignancy more likely after breast cancer — The Cancer Blog
Latest news from Radiology News from StratCenter.com:
- Genzyme increasing R&D presence in San Antonio area
- Eisai Breaks Ground for New Oncology Facility in Research Triangle Park
- Ashok Gupta, MD Joins the Physician Team at Desert Radiologists
- AMICAS Offers Free PACS Webinar for RSNA Attendees
- Enrollment Completed Utilizing Cytori's Adipose-Derived Stem Cell Technology for Treatment of Breast Cancer Complications
- Groundbreaking for Cancer Center on Premier Healh Campus - Middletown
- BSD Medical Sends Message of Hope at Largest Conference of US Radiation Oncologists
- Volcano to Offer 7.5M Shares
- Nautilus Biotech and Creabilis Therapeutics Achieve Technical Milestone in Collaboration to Improve HMGB1 Box A for the Treatment of Rage- and HMGB1-Related Pathologies.
- Adherex Reports Q3 2006 Financial Results